Work

Supplementary Tables 1 - 2 from A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 64KB, Supplementary Table S1. Descriptive statistics for concordance evaluation of positive control slides. Supplementary Table S2. Evaluation of laboratory data.

DOI: 10.1158/1940-6207.22525551

Authors: Kenneth G. Linden, Sancy A. Leachman, Jonathan S. Zager, James G. Jakowatz, Jaye L. Viner, Christine E. McLaren, Ronald J. Barr, Philip M. Carpenter, Wen-Pin Chen, Craig A. Elmets, Joseph A. Tangrea, Sung-Jig Lim, Alistair J. Cochran, Frank L. Meyskens

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362615455

Cites:

Cited by:

Related to: 10